Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells

Mikiro Takaishi1, Masahito Tarutani1, Junji Takeda2

  • 1Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.

Plos One
|June 4, 2016
PubMed

Insights

Reprogramming factors induce mesenchymal to epithelial transition (MET) in cancer cells, reducing their malignancy and metastasis. This MET process offers a potential new strategy for developing novel anticancer therapies targeting metastatic cancer.

Area of Science:

  • Oncology
  • Stem Cell Biology
  • Cancer Biology

Background:

  • Epithelial to mesenchymal transition (EMT) drives cancer metastasis, but effective therapies targeting this process are lacking.
  • Mesenchymal to epithelial transition (MET), the reverse of EMT, is observed in induced pluripotent stem cell generation.
  • Understanding MET in cancer could reveal new therapeutic strategies.

Purpose of the Study:

  • To investigate the effects of reprogramming factors (RFs) on squamous cell carcinoma (SCC) cells.
  • To determine if inducing MET in cancer cells can reduce their malignant potential.
  • To explore RFs as a potential therapeutic strategy against metastatic cancer.

Main Methods:

  • Introduction of reprogramming factors (RFs) into SCC cells to create RFs-introduced cancer cells (RICs).
  • Assessment of morphological and molecular changes (mRNA, microRNAs) in RICs.
  • In vitro evaluation of RICs' motility and invasive activities.
  • In vivo study using xenografts to assess lymph node metastasis in mice inoculated with RICs versus parental SCC cells.

Main Results:

  • RICs exhibited enhanced epithelial characteristics and altered gene/microRNA expression.
  • Motility and invasive activities of RICs were significantly reduced in vitro.
  • RIC xenografts showed no lymph node metastasis, unlike parental SCC xenografts.
  • RICs demonstrated a reversal of malignant phenotypes through MET.

Conclusions:

  • Inducing MET in SCC cells via RFs effectively reduces cancer cell malignancy and metastatic potential in vitro and in vivo.
  • The MET process in cancer cells, facilitated by RFs, represents a promising avenue for novel anticancer therapy development.
  • Targeting MET offers a potential strategy to combat metastatic cancer by reverting cells to a less aggressive epithelial state.

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
4.4K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K